About Opella
Opella is a company based in Neuilly-sur-seine (France) founded in 2019 was acquired by CD&R in October 2024. Opella offers products and services including OTC Products, VMS Products, and Self-Care Brands. Opella operates in a competitive market with competitors including Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma, among others.
- Headquarter Neuilly-sur-seine, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Opella Oü
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Opella
Opella offers a comprehensive portfolio of products and services, including OTC Products, VMS Products, and Self-Care Brands.
Over-the-counter items for everyday self-care and health needs
Vitamins and minerals supporting daily wellness and nutrition
Branded solutions for simple health management and prevention
Funding Insights of Opella
Detailed funding history for Opella
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Opella
Opella has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CD&R.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A private equity firm focused on building long-term business value.
|
Locked | Locked | Locked |
Investor details for Opella
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Opella
Investment portfolio details for Opella
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Opella
Detailed financials for Opella
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Opella Comparisons
Peer comparison for Opella
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Opella
Opella operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Multiple healthcare products and services are provided to organizations.
|
|
| Locked | Locked | Locked |
A distributor specializing in gelatin capsules for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
Serves as a distributor of specialty drugs.
|
|
| Locked | Locked | Locked |
Distributes anti-HIV, life-saving, and anti-cancer medicines to hospitals and patients.
|
|
| Locked | Locked | Locked |
Distributes super-speciality and general pharmaceuticals to chemists, hospitals, and patients.
|
|
| Locked | Locked | Locked |
Distributor and retailer of oncology medicines with partnerships in healthcare.
|
Detailed competitors of Opella
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Opella
Complete news archive for Opella
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Opella
Opella was founded in 2019.
Opella is headquartered in Neuilly-sur-seine, France. It is registered at Neuilly-sur-seine, Hauts-de-seine, France.
Julie Van Ongevalle is the current CEO of Opella.
Annual revenue of Opella is $27.35K as on Dec 31, 2023.
Opella was founded in 2019 as a distributor in the over-the-counter medicines, vitamins, minerals, and supplements sector. Operations focus on a global portfolio that includes well-known brands such as Allegra, Buscopan, Doliprane, Dulcolax, Enterogermina, Essentiale, and Mucosolvan. Leadership is provided by CEO and President Julie Van Ongevalle, with activities centered on product distribution and manufacturing support across international markets.
Opella's top competitors include Cardinal Health, Dvijay Pharma and ACG Associated Capsules.
Opella offers OTC Products, VMS Products, and Self-Care Brands.
Opella has 1 investor. Key investors include CD&R.